This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Stroke  • Neurology, Other  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Is In-Hospital Statin Initiation the Key?

Nerses Sanossian, MD; Jeffrey L. Saver, MD; David S. Liebeskind, MD; Doojin Kim, MD; Tannaz Razinia, BS; Bruce Ovbiagele, MD

Arch Neurol. 2006;63:1081-1083.

Background  National advisories recommend statin therapy as an element of secondary prevention for patients with ischemic stroke or transient ischemic attack of atherosclerotic origin. Statins are of proven benefit in persons at high risk of vascular disease.

Objectives  To evaluate the effects of in-hospital initiation of statins on 3-month treatment adherence rates and achievement of national guideline target cholesterol goals.

Methods  Data were collected in consecutively encountered patients with ischemic stroke or transient ischemic attack admitted to a university hospital stroke service beginning September 1, 2002. Patients were included in the study if they were not receiving a statin before admission and had an indication for statin therapy. Adherence to statin treatment and achievement of national guideline target cholesterol goals were assessed 3 months after discharge.

Results  From September 1, 2002, through April 30, 2005, 92 (17%) of 552 individuals met the study criteria. Hospital initiation of statin therapy yielded high rates of adherence (93% [86/92]), lowered mean low-density lipoprotein cholesterol levels from 120 to 78 mg/dL (3.1 to 2.0 mmol/L; P<.001), and increased the proportion of patients with low-density lipoprotein cholesterol levels lower than 100 mg/dL (2.6 mmol/L) from 36% to 88% (P<.001) at 3 months.

Conclusions  Statin initiation during hospitalization for an ischemic cerebrovascular event is associated with high rates of adherence to treatment, lowering of low-density lipoprotein cholesterol levels, and higher rates of achieving national cholesterol guidelines.

Author Affiliations: Stroke Center and Department of Neurology (Drs Sanossian, Saver, Liebeskind, Kim, and Ovbiagele and Ms Razinia), and Department of Neurology, Olive View (Drs Sanossian, Kim, and Ovbiagele), University of California, Los Angeles Medical Center.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment
Sanossian et al.
Stroke 2007;38:1104-1109.
ABSTRACT | FULL TEXT  

Intensive Statin Therapy After Stroke or Transient Ischemic Attack: A Sparcling Success?
Ovbiagele and Saver
Stroke 2007;38:1110-1112.
FULL TEXT  

Serum lipid profile on admission for ischemic stroke: Failure to meet National Cholesterol Education Program Adult Treatment Panel (NCEP-ATPIII) guidelines
Smith et al.
Neurology 2007;68:660-665.
ABSTRACT | FULL TEXT